CIK 0001566044
- Non-accelerated filer
- Smaller reporting company
Yarrow Bioscience, Inc.
Sign in to watch- Ticker
- YARW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 453757789
- Phone
- +1 203-433-7577
- Business address
- 470 JAMES STREET, SUITE 007, NEW HAVEN, CT, 06513
- Former names
- VYNE Therapeutics Inc., Menlo Therapeutics Inc., Menlo Therapeutics, Inc., Tigercat Pharma, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 2 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-03-09 | Hadar Ilan CFO and Country Manager | Grant or award · Stock Options | +14,291 | 14,291 | ||
| 2020-03-09 | Hadar Ilan CFO and Country Manager | Grant or award · Stock Options | +10,663 | 10,663 | ||
| 2020-03-09 | Hadar Ilan CFO and Country Manager | Grant or award · Stock Options | +119,667 | 119,667 | ||
| 2020-03-09 | Hadar Ilan CFO and Country Manager | Grant or award · Stock Options | +35,544 | 35,544 | ||
| 2020-03-09 | Hadar Ilan CFO and Country Manager | Grant or award · Stock Options | +35,774 | 35,774 | ||
| 2020-03-09 | Hadar Ilan CFO and Country Manager | Grant or award · Stock Options | +116,231 | 116,231 | ||
| 2020-03-09 | Hadar Ilan CFO and Country Manager | Grant or award · Stock Options | +20,789 | 20,789 | ||
| 2020-03-09 | Hadar Ilan CFO and Country Manager | Grant or award · Stock Options | +56,275 | 56,275 | ||
| 2020-03-09 | Hadar Ilan CFO and Country Manager | Grant or award · Stock Options | +57,086 | 57,086 | ||
| 2020-03-09 | Domzalski David President and CEO | Grant or award | +53,850 | 53,850 | ||
| 2020-03-09 | Domzalski David President and CEO | Grant or award | +138,102 | 191,952 | ||
| 2020-03-09 | Domzalski David President and CEO | Grant or award · Stock Options | +11,107 | 11,107 | ||
| 2020-03-09 | Domzalski David President and CEO | Grant or award · Stock Options | +140,286 | 140,286 | ||
| 2020-03-09 | Domzalski David President and CEO | Grant or award · Stock Options | +35,544 | 35,544 | ||
| 2020-03-09 | Domzalski David President and CEO | Grant or award · Stock Options | +42,278 | 42,278 | ||
| 2020-03-09 | Domzalski David President and CEO | Grant or award · Stock Options | +194,141 | 194,141 | ||
| 2020-03-09 | Domzalski David President and CEO | Grant or award · Stock Options | +41,578 | 41,578 | ||
| 2020-03-09 | Domzalski David President and CEO | Grant or award · Stock Options | +101,296 | 101,296 | ||
| 2020-03-09 | Domzalski David President and CEO | Grant or award · Stock Options | +142,716 | 142,716 | ||
| 2020-03-09 | Bright Rex Director | Grant or award · Stock Options | +15,994 | 15,994 |
Page 16 of 22 · 425 trades